Peter Greenleaf
2019 - Aurinia Pharmaceuticals
In 2019, Peter Greenleaf earned a total compensation of $5.2M as Chief Executive Officer at Aurinia Pharmaceuticals.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $368,137 |
| Option Awards | $4,176,172 |
| Salary | $438,258 |
| Other | $4,063 |
| Total | $5,236,630 |
Greenleaf received $4.2M in option awards, accounting for 80% of the total pay in 2019.
Greenleaf also received $250K in bonus, $368.1K in non-equity incentive plan, $438.3K in salary and $4.1K in other compensation.
Rankings
In 2019, Peter Greenleaf's compensation ranked 2,069th out of 13,971 executives tracked by ExecPay. In other words, Greenleaf earned more than 85.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,069 out of 13,971 | 85th |
Division Manufacturing | 755 out of 5,701 | 87th |
Major group Chemicals And Allied Products | 232 out of 2,200 | 90th |
Industry group Drugs | 187 out of 1,886 | 90th |
Industry Pharmaceutical Preparations | 135 out of 1,398 | 90th |
Source: SEC filing on May 10, 2021.
Greenleaf's colleagues
We found two more compensation records of executives who worked with Peter Greenleaf at Aurinia Pharmaceuticals in 2019.
News
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
April 18, 2022
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
May 10, 2021
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019